A brain-body feedback loop driving HPA-axis dysfunction in breast cancer

Adrian Gomez,Yue Wu,Chao Zhang,Leah Boyd,Tse-Luen Wee,Joseph Gewolb,Corina Amor,Lucas Cheadle,Jeremy C. Borniger

DOI: https://doi.org/10.1101/2024.09.13.612923

2024-09-14

Abstract:Breast cancer patients often exhibit disrupted circadian rhythms in circulating glucocorticoids (GCs), such as cortisol. This disruption correlates with reduced quality of life and higher cancer mortality . The exact cause of this phenomenon — whether due to treatments, stress, age, co-morbidities, lifestyle factors, or the cancer itself remains unclear. Here, we demonstrate that primary breast cancer alone blunts host GC rhythms by disinhibiting neurons in the hypothalamus, and that circadian phase-specific neuromodulation of these neurons can attenuate tumor growth by enhancing anti-tumor immunity. We find that mice with mammary tumors exhibit blunted GC rhythms before tumors are palpable, alongside increased activity in paraventricular hypothalamic neurons expressing corticotropin-releasing hormone (i.e., PVN neurons). Tumor-bearing mice have fewer inhibitory synapses contacting PVN neurons and reduced miniature inhibitory post-synaptic current (mIPSC) frequency, leading to net excitation. Tumor-bearing mice experience impaired negative feedback on GC production, but adrenal and pituitary gland functions are largely unaffected, indicating that alterations in PVN neuronal activity are likely a primary cause of hypothalamic-pituitary-adrenal (HPA) axis dysfunction in breast cancer. Using chemogenetics (hM3Dq) to stimulate PVN neurons at different circadian phases, we show that stimulation just before the light-to-dark transition restores normal GC rhythms and reduces tumor progression. These mice have significantly more effector T cells (CD8+) within the tumor than non-stimulated controls, and the anti-tumor effect of PVN neuronal stimulation is absent in mice lacking CD8+ T cells. Our findings demonstrate that breast cancer distally regulates neurons in the hypothalamus that control output of the HPA axis and provide evidence that therapeutic targeting of these neurons could mitigate tumor progression.

Neuroscience

What problem does this paper attempt to address?

This paper attempts to address the issue of disrupted circadian rhythms of circulating glucocorticoids (GCs) such as cortisol in breast cancer patients. This disruption is associated with a decline in quality of life and higher cancer mortality rates. Specifically, the paper explores whether breast cancer itself can independently affect the circadian rhythms of GCs in the host, apart from other factors such as treatment, stress, age, comorbidities, or lifestyle factors. The study found that breast cancer can weaken the host's GC rhythms by remotely inhibiting specific neurons in the hypothalamus (namely PVNCRH neurons). Furthermore, by using chemogenetic stimulation of PVNCRH neurons at different times of the day, normal GC rhythms can be restored, and tumor growth can be slowed. This effect depends on the presence of CD8+ T cells rather than the direct action of GCs. The paper also proposes several future research directions, including how tumors remotely affect PVNCRH neuron function and which cells are responsible for reducing inhibitory input.